Table 2.
Univariate analysis comparing survivors and non-survivors with HSV infections supported on ECMO
| Variables | Odds Ratio |
P value |
95% confidence interval |
|
|---|---|---|---|---|
| Age (days) | 1.070 | 0.403 | 0.916 | 1.244 |
| Gestational Age | 1.190 | 0.305 | 0.851 | 1.673 |
| Female Gender | 0.629 | 0.573 | 0.138 | 2.990 |
| Weight (kg) | 1.249 | 0.696 | 0.409 | 3.810 |
| White race | 0.750 | 0.702 | 0.172 | 3.280 |
| ≥ 2000 Era | 0.667 | 0.585 | 0.156 | 2.852 |
| VA ECMO | 4.333 | 0.081 | 0.836 | 22.47 |
| Septicemia/ shock | 5.000 | 0.044 | 1.042 | 23.99 |
| Pulm hypertension | 0.765 | 0.714 | 0.182 | 3.210 |
| Dissem. Intravascular Coag. | 5.211 | 0.141 | 0.580 | 46.81 |
| pH | 0.401 | 0.014 | 0.194 | 0.830 |
| PaO2/ FiO2 ratio | 0.999 | 0.916 | 0.976 | 1.022 |
| PaCO2 | 0.963 | 0.183 | 0.982 | 1.098 |
| HCO3 | 0.853 | 0.035 | 0.735 | 0.989 |
| SaO2 | 0.941 | 0.062 | 0.883 | 1.003 |
| Renal replacement therapy | 0.286 | 0.099 | 0.064 | 1.264 |